BlackRock Fund Advisors’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $67.7M | Buy |
853,285
+83,416
| +11% | +$6.62M | 0.01% | 1479 |
|
|
2016
Q3 | $53.9M | Buy |
769,869
+358,134
| +87% | +$25.1M | 0.01% | 1523 |
|
|
2016
Q2 | $16M | Buy |
411,735
+2,501
| +0.6% | +$97K | ﹤0.01% | 2158 |
|
|
2016
Q1 | $16.6M | Buy |
409,234
+16,137
| +4% | +$654K | ﹤0.01% | 2086 |
|
|
2015
Q4 | $34.9M | Buy |
393,097
+188,598
| +92% | +$16.7M | 0.01% | 1720 |
|
|
2015
Q3 | $15.1M | Sell |
204,499
-980
| -0.5% | -$72.5K | ﹤0.01% | 2164 |
|
|
2015
Q2 | $16.6M | Buy |
205,479
+196,603
| +2,215% | +$15.9M | ﹤0.01% | 2226 |
|
|
2015
Q1 | $372K | Buy |
8,876
+5,645
| +175% | +$237K | ﹤0.01% | 3316 |
|
|
2014
Q4 | $50K | Buy |
+3,231
| New | +$50K | ﹤0.01% | 3673 |
|
|
2014
Q2 | – | Sell |
-78,665
| Closed | -$1M | – | 3902 |
|
|
2014
Q1 | $1M | Buy |
+78,665
| New | +$1M | ﹤0.01% | 3191 |
|